Aggrastat, in combination with heparin, is indicated for patients with unstable angina or non-Q-wave myocardial infarction to prevent cardiac ischemic events and is also indicated for patients with coronary ischemic syndromes undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications related to abrupt closure of the treated coronary artery. (See Pharmacology under Actions and Dosage & Administration.)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
